Fahrenheit Chemoleums Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 02-12-2024
- Paid Up Capital ₹ 0.10 M
as on 02-12-2024
- Company Age 14 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 1.85%
(FY 2022)
- Profit 9.40%
(FY 2022)
- Ebitda 0.17%
(FY 2022)
- Net Worth 11.13%
(FY 2022)
- Total Assets -53.11%
(FY 2022)
About Fahrenheit Chemoleums
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Pankaj Sukhia, Deva Sukhia, and Nitin Sukhia serve as directors at the Company.
- CIN/LLPIN
U24100DL2010PTC208134
- Company No.
208134
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Sep 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Fahrenheit Chemoleums Private Limited offer?
Fahrenheit Chemoleums Private Limited offers a wide range of products and services, including Oils, Grease & Lubricants, Engine Oil, Grease, Automotive Oils, Gear Oil, EP 90 Gear Oil, Industrial Oils, Hydraulic Oils, Automotive Grease, Ap3 Grease.
Who are the key members and board of directors at Fahrenheit Chemoleums?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pankaj Sukhia  | Director | 10-Sep-2010 | Current |
| Deva Sukhia | Director | 10-Sep-2010 | Current |
| Nitin Sukhia | Director | 10-Sep-2010 | Current |
Financial Performance and Corporate Structure Insights of Fahrenheit Chemoleums.
Fahrenheit Chemoleums Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 1.85% increase. The company also saw a slight improvement in profitability, with a 9.4% increase in profit. The company's net worth Soared by an impressive increase of 11.13%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Fahrenheit Chemoleums?
In 2020, Fahrenheit Chemoleums had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Fahrenheit Chemoleums?
Unlock and access historical data on people associated with Fahrenheit Chemoleums, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Fahrenheit Chemoleums, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fahrenheit Chemoleums's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
